Scarica l'app Stockscreener
9.18
0.99%
0.09
Dopo l'orario di chiusura:
9.18
Meiragtx Holdings Plc Borsa (MGTX) Ultime notizie
MeiraGTx (NASDAQ:MGTX) Upgraded by Wall Street Zen to "Hold" Rating - marketbeat.com
(MGTX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
MGTX Technical Analysis & Stock Price Forecast - Intellectia AI
What Does The Future Hold For MeiraGTx Holdings plc (NASDAQ:MGTX)? These Analysts Have Been Cutting Their Estimates - Sahm
MeiraGTx Holdings plc Ordinary Shares MGTX ) Stock Price Today & Analysis - Gotrade
MeiraGTx Holdings plc Ordinary Shares (MGTX) Stock Price Today & Analysis - heygotrade.com
MGTX: Evercore ISI Group Lowers Price Target for MeiraGTx Hldgs | MGTX Stock News - GuruFocus
MGTX: Evercore ISI Group Lowers Price Target for MeiraGTx Hldgs - GuruFocus
MeiraGTx Holdings PLC $MGTX Shares Bought by Hennion & Walsh Asset Management Inc. - marketbeat.com
Strength Displayed by MeiraGTx (MGTX): Will Its 6.2% Surge Lead to Further Gains? - Bitget
Strength Seen in MeiraGTx (MGTX): Can Its 6.2% Jump Turn into More Strength? - Yahoo Finance
Performance Recap: Can MeiraGTx Holdings plc deliver consistent EPS growth2026 Rallies & Community Trade Idea Sharing Platform - baoquankhu1.vn
MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know - simplywall.st
MeiraGTx Holdings plc (NASDAQ:MGTX) Just Reported And Analysts Have Been Cutting Their Estimates - Yahoo Finance
MeiraGTx 2025 Annual Report Highlights: Gene Therapy Pipeline, Strategic Partnerships, and Proprietary Riboswitch Platform - Minichart
MeiraGTx 2025 10-K: Revenue $81.4M, EPS (1.42) - TradingView
MeiraGTx (NASDAQ: MGTX) expands gene therapy partnerships and manufacturing - Stock Titan
MeiraGTx Holdings plc (MGTX) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union
Live MeiraGTx Holdings plc (MGTX) Technical Analysis - tradersunion.com
Chardan Capital Reiterates “Buy” Rating for MeiraGTx (NASDAQ:MGTX) - Defense World
MeiraGTx Holdings plc (MGTX) Stock Price, News, Quote & History - Yahoo! Finance Canada
MGTX SEC FilingsMeiragtx Holdings Plc 10-K, 10-Q, 8-K Forms - Stock Titan
MeiraGTx Holdings PLC (MGTX) Q4 earnings and revenues surpass estimates - MSN
Piper Sandler cuts MeiraGTx stock price target on valuation By Investing.com - Investing.com Australia
Piper Sandler Lowers MeiraGTx (NASDAQ:MGTX) Price Target to $26.00 - MarketBeat
Piper Sandler cuts MeiraGTx stock price target on valuation - Investing.com UK
MeiraGTx (NASDAQ:MGTX) Issues Earnings Results - marketbeat.com
MeiraGTx (NASDAQ:MGTX) Price Target Raised to $16.00 at Bank of America - MarketBeat
MeiraGTx (NASDAQ:MGTX) Earns Buy Rating from Chardan Capital - MarketBeat
MeiraGTx Receives FDA Breakthrough Therapy Designation for AAV2-hAQP1 and Reports Strong 2025 Financial Results - Minichart
BofA raises MeiraGTx stock price target to $16 on FDA designation - uk.investing.com
BofA raises MeiraGTx stock price target to $16 on FDA designation By Investing.com - Investing.com India
MeiraGTx Highlights Breakthrough Gene Therapy and Strategic Alliances - TipRanks
MeiraGTx (NASDAQ:MGTX) Sees Strong Trading VolumeShould You Buy? - MarketBeat
MeiraGTx shares see Raymond James price target cut on launch timing By Investing.com - Investing.com South Africa
MeiraGTx shares see Raymond James price target cut on launch timing - Investing.com UK
MeiraGTx Holdings PLC (MGTX) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
MGTX Receives Breakthrough Designation for Xerostomia Treatment - GuruFocus
MeiraGTx Extends Perceptive Notes to May 2027, Plans $25M Redemption; Warrants Repriced to $8 - TradingView
MeiraGTx (Nasdaq: MGTX) gains FDA breakthrough tag and extends debt maturity - Stock Titan
MeiraGTx Announces FDA Breakthrough Therapy Designation for AAV2-hAQP1 for the Treatment of Grade 2 and Grade 3 Radiation-Induced Xerostomia (RIX) and Reports Fourth Quarter and Full Year 2025 Financial and Operational Results - The Manila Times
FDA grants breakthrough status to MeiraGTx dry-mouth gene therapy - Stock Titan
MeiraGTx Highlights Late-Stage Gene Therapy Pipeline at RBC Ophthalmology Conference - MarketBeat
MeiraGTx (NASDAQ:MGTX) CEO Sells $459,420.00 in Stock - MarketBeat
MeiraGTx Holdings plc (MGTX) Stock Price Prediction for 2026, 2030-2040 - Traders Union
Meiragtx Holdings Insider Sold Shares Worth $459,420, According to a Recent SEC Filing - marketscreener.com
Insider Sell Alert: Alexandria Forbes Sells 62,000 Shares of Mei - GuruFocus
Forbes Alexandria, president & CEO of MeiraGTx, sells $459k in MGTX stock By Investing.com - Investing.com South Africa
Forbes Alexandria, president & CEO of MeiraGTx, sells $459k in MGTX stock - Investing.com
MeiraGTx (MGTX) CEO sells 62K shares at $7.41 under 10b5-1 plan - Stock Titan
How (MGTX) Movements Inform Risk Allocation Models - Stock Traders Daily
Earnings Report: Is MeiraGTx Holdings plc gaining market shareForecast Cut & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Should I invest in MeiraGTx Holdings plc before earningsMarket Sentiment Review & Low Risk High Win Rate Picks - baoquankhu1.vn
MeiraGTx Holdings PLC (NASDAQ:MGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
MGTX PE Ratio & Valuation, Is MGTX Overvalued - Intellectia AI
MeiraGTx Holdings PLC $MGTX Shares Sold by Prosight Management LP - MarketBeat
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):